EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
91 hedge funds and large institutions have $54.8M invested in Eagle Pharmaceuticals, Inc. in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 38 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
92% less call options, than puts
Call options by funds: $16K | Put options by funds: $202K
Holders
91
Holding in Top 10
–
Calls
$16K
Puts
$202K
Top Buyers
| 1 | +$6.6M | |
| 2 | +$6.22M | |
| 3 | +$2.02M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$726K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$595K |
Top Sellers
| 1 | -$4.06M | |
| 2 | -$3.9M | |
| 3 | -$1.39M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.23M |
| 5 |
Morgan Stanley
New York
|
-$1.14M |